Elon, Serena, Joe Rogan ... and University of Utah health researcher Wesley Sundquist among Time's '100 Most Influential People of 2025'
But that's exactly where University of Utah biochemist Wesley Sundquist can be located on Time Magazine's '100 Most Influential People of 2025.″
Sundquist is the first to admit his inclusion alongside the Musks, Williams and Rogans of the world is not what he ever expected while laboring in the medical research community.
'It was really a surprise that came out of the blue,' Sundquist told the Deseret News. 'It was kind of a thrill.'
But colleagues in the medical science community believe that Sundquist's spot on the magazine's eclectic list is well-deserved.
Sundquist is included in the magazine's annual list for his lab's research leading to a drug that prevents HIV infections.
The drug, lenacapavir, was developed at the biopharmaceutical company Gilead Sciences, and is 'exceptionally effective' at preventing HIV. A single dose provides protection for six months, according to a University of Utah Health release.
Sundquist consulted with Gilead Sciences, which developed lenacapavir. His collaborator at Gilead, Tomas Cihlar, is a co-recipient of TIME's 'influential' honor.
The Time 100 list, which is slated for the April 28, 2025 issue, includes Sundquist and Cihlar in the list's 'Pioneers' category.
The magazine's short essay on the two men noted that today's antiviral medications can turn HIV, a once fatal disease, into a chronic condition. However, the cocktail of pills remains inaccessible for many — and lapses in the daily regimen make them less effective.
Sundquist and Cihlar, the essay adds, 'have labored for more than a dozen years to turn one antiviral treatment, lenacapavir, into a twice-a-year therapy to prevent HIV infection in those at high risk.
Sundquist, according to the magazine, laid the groundwork in studying one of HIV's proteins, the capsid, which creates a protective shell around the virus' genome.
'Cihlar visited his labs and was impressed enough to take his discoveries to Gilead. There, his team found ways to extend the effect of the drug over six months, meaning infected patients only receive two injections a year to treat HIV.'
The Time essay concludes saying researchers are now studying lenacapavir in people who are not HIV positive but are at high risk of exposure. 'If approved, it would be the first twice-a-year injected drug to prevent HIV. Early results show great promise.'
In multiple clinical trials involving tens of thousands of people, lenacapavir has shown 99.9 to 100 percent efficacy in preventing HIV — results that Sundquist describes as 'spectacularly successful', according to the university release.
If distributed broadly, the drug reportedly has the potential to dramatically decrease infection rates worldwide. 'It feels like our work has made a difference,' Sundquist adds.
The scientist told the Deseret News on Wednesday that his 'real excitement' is found in the drug's potential in protecting against new infections.
'Worldwide, there are still 1.3 million new infections ever year,' he said. 'This has the promise to help prevent that and really change the course of the pandemic, especially in the developing world.'
Lenacapavir's story began decades ago 'with basic, curiosity-driven research in Sundquist's lab,' according to the university.
The lab wasn't specifically aiming to discover new therapies — they were simply trying to understand how the HIV virus particle is put together. They discovered that one of the key components of the virus is extremely sensitive to change: a prime target for drug development.
'Today, we recognize Dr. Sundquist for his work that began more than 20 years ago as a quest to understand the structure of HIV and has now led to a medication that could prevent the spread of HIV worldwide,' says Dr. Rachel Hess, Associate Vice President for Research at University of Utah Health in the university release.
'This is an amazing example of fundamental research creating the environment to improve health around the globe.'
Added Dr. Bob Carter, CEO for University of Utah Health and Senior Vice President for Health Sciences: 'We're honored that the global impact of his work has been recognized and incredibly proud that his work continues at U of U Health.'
Next week, Sundquist and fellow Time 'influencers' will be honored at New York's Lincoln Center.
'It's supposed to be a black tie, red carpet kind of thing, which is not my style,' he said, laughing. 'But I think it'll be a lot of fun.'
On a serious note, Sundquist hopes the Time magazine honor brings attention to the importance of continued medical research support and funding from the National Institutes of Health (NIH).
'We're a basic research lab, and as you may know, that's under considerable turmoil right now,' he said. 'So labs like mine function because we have sustained support from the NIH.'
Delivering to patients the sorts of drugs that Sundquist and his colleagues have worked decades to develop requires resources. 'And that's also under threat right now.'
The scientist added he is a supporter of 'basic research'.
'We never know how it's going to result in important advances, but inevitably, across the field and across time, it does result in important advances,' said Sundquist. 'If we support it, it has a very strong track record — and if we don't, we'll (risk) losing our feedstocks for new ideas in medicine.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
38 minutes ago
- UPI
State Department to burn birth control worth $9.7M meant for poor nations
The U.S. government plans to destroy $9.7 million of contraceptives for poor nations, mainly in Africa, after the nation "explored all possible options to prevent the destruction." UPI file photo | License Photo July 27 (UPI) -- The U.S. government plans to destroy a stockpile of contraceptives worth $9.7 million for poor nations, mainly in Africa, after the State Department "explored all possible options to prevent the destruction." The contraceptives include nearly 2 million doses of injectables, 900,000 implantable devices and more than 2 million oral packets, according to internal auditing in April obtained by The Washington Post. Chelsea Polis, a researcher with Guttsmacher Institute, which supports abortion rights, told the newspaper that the contraceptives could provide more than 650,000 women with pregnancy protection for up to one year and 950,000 women for three years. U.S. laws and rules prohibit sending U.S. aid to organizations that provide abortion services, counsel about the procedure or advocate for the right overseas. "The State Department confirms that a preliminary decision was made to destroy certain abortifacient birth control commodities from terminated Biden-era USAID contracts," a spokesperson said in a statement. "Only a limited number of commodities have been approved for disposal. No HIV medications or condoms are being destroyed." The destruction will cost $167,000, the spokesperson said. Most contraceptives have less than 70% of shelf life before expiration, the spokesperson said. The Guardian contacted an aide who visited the warehouse in Belgium and found the earliest expiration date was 2027. Two-thirds didn't have any labels. Belgium, the United Nations and humanitarian groups said they unsuccessfully stopped the destruction plans for the contraceptives. The U.S. Agency for International Development, which Trump disbanded and merged into the State Department, was to have distributed them. They are part of a $9.5 billion program over 10 years to provide aid to more than 40 nations. The government said it based its decision on a policy that restricts funding for reproductive-related actions in the Mexico City Policy and the Kemp-Kasten amendment. President Ronald Reagan instituted the policy in 1985 and it has become a political issue. It has rescinded by Democratic presidents and reinstated by Republicans several times, including by President Donald Trump when he returned to office in January. A bipartisan group of U.S. legislators doesn't want the contraceptives to be destroyed, including Republican Sens. Lisa Murkowski of Alaska, and Democrats Jeanne Shaheen of New Hampshire and Brian Schatz of Hawaii. "This is a waste of U.S. taxpayer dollars and an abdication of U.S. global leadership in preventing unintended pregnancies, unsafe abortions and maternal deaths," said Shaheen, who in June sent a letter to the Secretary of State Marco Rubio about the matter. The U.N. Population Fund and the International Planned Parenthood Federation were interested in receiving the contraceptives. "UNFPA was in conversation with Chemonics about purchasing the contraceptives but didn't receive an answer from them," UNFPA spokesman Eddie Wright said. "It's the height of hypocrisy for a government to preach efficiency and cutting waste, only to turn around and recklessly destroy lifesaving supplies when the need has never been greater," Micah Grzywnowicz, regional director of the International Planned Parenthood Federation European Network, said in a statement MSI Reproductive Choices offered to pay for shipping and repackaging. MSI provides abortion services. "The complete dismantling of the world's largest donor for international family planning has been a catastrophe for the global supply chain of contraceptives," said Sarah Shaw, associate director of advocacy and for the organization. Sub-Saharan Africa has experienced an increase in teen births, according to a study at Columbia University in 2024. The number of births climbed from 4.5 million births in 2000 to 6.1 million in 2021as they decreased in the rest of the world. In Africa, 30% of all woman use birth control but more than half would use it if available, according to DebboAfrica, a healthcare company for African women. Worldwide, around half of women of reproductive age of 15-19 use some form of contraception, according to Focus2030. Foreign aid cuts could lead to more than 14 million additional deaths by 2023, including two-thirds children, according to a study published in Lancet earlier this month. Congress earlier this month passed legislation to remove $8 billion in foreign assistance. The Atlantic reported earlier this month that 551 tons of emergency food were expiring and will be incinerated rather than being fed to almost 1.5 million children in Afghanistan and Pakistan. Almost 800,000 Mpox vaccines to be sent to Africa also are not usable because they are past their expiration date, Politico reported earlier this month.
New York Post
a day ago
- New York Post
3 critical signs of cardiac arrest in the wake of Hulk Hogan's death
Hulk Hogan has wrestled his last match — taken down not by a rival in the ring, but by one of America's top killers: cardiac arrest. News broke Thursday morning that the wrestling icon, born Terry Gene Bollea, had died after weeks of declining health. 'He was suffering from shortness of breath, got tired easily, had lost a lot of weight and was on oxygen as his life ebbed away at his mansion in Clearwater, Florida,' an insider alleged to the Daily Mail. 6 Getty Images While Hogan, 71, may have built his legacy surviving body slams and steel cages, cardiac arrest proved to be one opponent even the handlebar-mustachioed marvel couldn't overpower. Globally, the condition claims more lives each year than colorectal cancer, breast cancer, prostate cancer, pneumonia, car crashes, the flu, HIV and house fires combined, according to the American Heart Association. In the US alone, cardiac arrest kills more than 436,000 Americans every year — making it one of the nation's deadliest health threats. Here's everything you need to know about this heart-stopping emergency and how to act before it's too late. What is cardiac arrest? It's a deadly medical emergency where the heart suddenly stops beating — or beats so erratically that it can't pump blood at all, according to the Cleveland Clinic. 6 Anciens – When that happens, oxygen stops flowing to the brain and vital organs. Within minutes, the body starts shutting down — and without immediate help, the chances of death are high. Despite common confusion, cardiac arrest is not the same as a heart attack. A heart attack is a circulation problem caused by a blocked artery that cuts off blood flow to the heart muscle. Cardiac arrest, by contrast, is an electrical malfunction. The heart's rhythm goes haywire, and the muscle flatlines. Who's at risk for cardiac arrest? The most common cause of sudden cardiac arrest is an irregular heart rhythm called ventricular fibrillation, which keeps the heart from pumping blood effectively, according to the Mayo Clinic. Certain heart conditions — like coronary artery disease, heart valve problems, and a history of heart attacks — can increase the risk of this dangerous rhythm. But cardiac arrest can also strike people with no known heart issues. Other factors that may increase your chances include: Smoking or heavy alcohol/drug use High blood pressure or cholesterol Low potassium or magnesium levels Obesity Diabetes Sleep apnea Chronic kidney disease A sedentary lifestyle A family history of heart disease or cardiac arrest While the risk of cardiac arrest increases with age, it can strike at any time — even in children. In fact, sudden cardiac arrests happen in about 1 in every 70 schools each year, often impacting young athletes. 6 Hulk Hogan had faced a slew of health issues and suffered from a 'weak heart' in the lead-up to his death. George Napolitano / Men generally face higher odds of cardiac arrest, but women's risk rises after menopause. Warning signs to watch for 'The typical signs of a cardiac arrest include abrupt loss of consciousness with eyes rolled back, seizure-like activity due to lack of oxygen flow to the brain, and irregular, labored or no breathing,' Dr. Irfan Asif, professor and chair of the Department of Family and Community Medicine University of Alabama at Birmingham, said in an interview. He added that someone suffering cardiac arrest may have a very weak pulse — or no pulse at all. 6 A sudden collapse is usually the first noticeable sign of sudden cardiac arrest. Rainer Fuhrmann – Other warning signs that can come before cardiac arrest include chest discomfort, shortness of breath, weakness and heart palpitations like a fast-beating, fluttering or pounding heart. But here's the kicker: Sometimes there are no warnings at all. That's why knowing how to respond can mean the difference between life and death. What should you do if someone goes into cardiac arrest? 'If you are experiencing a cardiac arrest, try to get to a place where you are not alone, or signal to someone you are in distress before you are incapacitated,' Dr. John Bozinovski, a cardiac surgeon at The Ohio State University Wexner Medical Center, told HuffPost. If you see someone collapse and suspect cardiac arrest, act fast. First, check if they're responsive by loudly asking, 'Are you okay?' and gently shaking their shoulders. Look for a pulse and check if they're breathing normally, according to the University of California, Davis. 6 AED's are commonly found in public places like airports, schools, shopping malls, office buildings and sporting venues. brostock – If others are nearby, assign someone to call 911 and another to find an automated external defibrillator (AED), which can shock the heart back to rhythm. If you're alone, call 911 yourself and put the phone on speaker. For children, start CPR right away. For adults, get the AED quickly, as it's usually a heart issue. To perform CPR, lay the person on their back on a firm surface, tilt their head back to open the airway, and check for breathing. If they're not breathing, begin chest compressions: place your hands, one on top of the other, in the center of the chest, pressing hard (about 2 inches deep for adults) at 100–120 compressions per minute. 6 CPR can help maintain blood flow and oxygenation until emergency responders arrive. THANAGON – Use the AED as soon as it arrives and follow its prompts. Alternate CPR and AED use until help arrives or the person wakes up. Every minute without intervention after a cardiac arrest lowers survival chances by 10%. Yet fewer than half receive timely help, according to the American Red Cross. While CPR or AED use can double or triple survival odds, studies show bystanders use an AED only 7% of the time and perform CPR 42% of the time when witnessing a public cardiac arrest. Experts are urging everyone to learn CPR to boost those numbers. 'Everyone should take an in-person CPR course at least once, with a refresher every two to three years,' Dr. Eric Goralnick, associate professor of emergency medicine at Harvard Medical School, advised. 'You could save the life of a family member, friend, or even a stranger,' he added, noting that many CPR classes also cover first aid and AED use.
Yahoo
a day ago
- Yahoo
Assembly Bio's (ASMB) HBV Drug Shows Strong Efficacy in Phase 1b Trial
Assembly Biosciences, Inc. (NASDAQ:ASMB) is one of the growth stocks that could double by 2027. On June 25, the company announced positive topline results from its Phase 1b trial of ABI-4334, a capsid assembly modulator for the treatment of chronic hepatitis B. A scientist in a white lab coat working at a bench with biopharmaceutical equipment. The 28-day study showed HBV DNA reductions of 2.9 log10 IU/mL at 150 mg and 3.2 log10 IU/mL at 400 mg, with additional declines in HBV RNA. The lower dose achieved saturated inhibition of viral replication, while the higher dose may enhance suppression of cccDNA formation, a key viral reservoir. The drug was well-tolerated, with no serious adverse events and pharmacokinetics supporting once-daily oral dosing. These results activate a licensing decision for Gilead Sciences, which holds rights to further develop ABI-4334. Assembly Biosciences, Inc. (NASDAQ:ASMB) is a clinical-stage biotech focused on small-molecule therapies for serious viral infections. Its pipeline includes candidates for hepatitis B, hepatitis delta, herpesviruses, and transplant-related infections. The company collaborates with Gilead Sciences to advance next-generation antiviral treatments. While we acknowledge the potential of ASMB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
